A review of CBRN topics related to military and civilian patient exposure and decontamination
DOI:
https://doi.org/10.5055/ajdm.2019.0324Keywords:
CBRN, decontamination, biological, chemical, decontaminantsAbstract
Chemical and biological (CB) warfare have long been practiced, and although these types of warfare are not acceptable in modern times, this does not prevent them from occurring. This makes it important for societies to be able to appropriately respond to these events, including the best way to decontaminate victims to keep them and emergency responders safe. Decontamination methods such as chemical, physical, wet, and dry methods are discussed, as well as their downsides. Secondary contamination, which played a significant role in the Tokyo sarin attacks, has long been noted by anecdotal evidence, although it has been little studied. Biological agents cause more problems after infection has taken place, and thus preventing the spread of infection is the largest concern. There are many differences between military and civilian populations, and the response to mass casualty attacks differs accordingly. There are several emerging technologies that can make this process easier on all parties, such as bioscavengers, antitoxins, and color changing bleach for visualization. A reliable way to quantify decontamination is also needed, which would allow for better care of victims both in normal hospital situations, as well as during aeromedical transport. In addition, several gaps were identified, such as the lack of scientific basis for 90 percent reduction during decontamination, a way to quantify decontamination, and the lack of studies on toxic industrial chemicals and secondary contamination.
References
Salem H, Ternay Jr AL, Smart JK: Brief history and use of chemical warfare agents in warfare and terrorism. In Romano JAJ, Lukey BJ, Salem H (eds.): Chemical Warfare Agents: Chemistry, Pharmacology, Toxicology, and Therapeutics. 2nd ed. Boca Raton, FL: Taylor & Francis Group, 2013: 1-20.
OPCW: Convention on the prohibition of the development, production, stockpiling and use of chemical weapons and on their destruction. Organisation for the Prohibition of Chemical Weapons. The Hague, The Netherlands: Technical Secretariat of the Organisation for the Prohibition of Chemical Weapons, 2005: 1-181. Available at https://www.opcw.org/sites/default/files/documents/CWC/CWC_en.pdf. Accessed May 22, 2019.
US Department of Air Force: Potential Military Chemical/ Biological Agents and Compounds. AFTTP(I) 3-2.55. Washington, DC: US Department of Air Force, 2005: V1-V6. Available at https://fas.org/irp/doddir/army/fm3-11-9.pdf. Accessed May 22, 2019.
Lake W, Divarco S, Schulze P, et al.: Updated Guidelines for Mass Casualty Decontamination During a HAZMAT/Weapon of Mass Destruction Incident, Volumes I and II. ECBC-SP-036. Aberdeen Proving Ground, MD: Edgewood Chemical Biological Center, 2013: 1-302.
Koenig KL, Boatright CJ, Hancock JA, et al.: Health care facility-based decontamination of victims exposed to chemical, biological, and radiological materials. Am J Emerg Med. 2008; 26(1): 71-80. doi:10.1016/j.ajem.2007.07.004.
Fatah AA, Arcilesi RD, Judd AK, et al.: Guide for the Selection of Chemical, Biological, Radiological, and Nuclear Decontamination Equipment for Emergency First Responders. Washington, DC: US Department of Homeland Security, 2007. Available at https://ws680.nist.gov/publication/get_pdf.cfm?pub_id=911304. Accessed October 28, 2018.
Thors L, Koch M, Wigenstam E, et al.: Comparison of skin decontamination efficacy of commercial decontamination products following exposure to VX on human skin. Chem Biol Interact. 2017; 273: 82-89. doi:10.1016/j.cbi.2017.06.002.
Thors L, Lindberg S, Johansson S, et al.: RSDL decontamination of human skin contaminated with the nerve agent VX. Toxicol Lett. 2017; 269: 47-54. doi:10.1016/j.toxlet.2017.02.001.
Matar H, Price SC, Chilcott RP: Further studies of the efficacy of military, commercial and novel skin decontaminants against the chemical warfare agents sulphur Mustard, Soman and VX. Toxicol In Vitro. 2019; 54: 263-268. doi:10.1016/j.tiv.2018.10.008.
Salerno A, Bolzinger M-A, Rolland P, et al.: Pickering emulsions for skin decontamination. Toxicol In Vitro. 2016; 34: 45-54. doi:10.1016/j.tiv.2016.03.005.
Solon JG, Killeen S: Decontamination and sterilization. Surgery. 2015; 33(11): 572-578. doi:10.1016/J.MPSUR.2015.08.006.
McGlone MM, Teece SC: Management of the poisoned patient. Anaesth Intensive Care Med. 2016; 17(10): 506-509. doi:10.1016/j.mpaic.2016.07.004.
D’Amelio E, Gentile B, Lista F, et al.: Historical evolution of human anthrax from occupational disease to potentially global threat as bioweapon. Environ Int. 2015; 85: 133-146. doi:10.1016/j.envint.2015.09.009.
Currie J, Heslop DJ: Operational systems evaluation of a large scale multi-agency decontamination exercise. Int J Disaster Risk Reduct. 2018; 31: 1054-1061. doi:10.1016/j.ijdrr.2018.03.027.
Hudson TL, Reilly K, Dulaigh J: Considerations for chemical decontamination shelters. Disaster Manag Response. 2003; 1(4): 110-113. doi:10.1016/j.dmr.2003.10.001.
Hick JL, Hanfling D, Burstein JL, et al.: Protective equipment for health care facility decontamination personnel: Regulations, risks, and recommendations. Ann Emerg Med. 2003; 42(3): 370-380. doi:10.1067/mem.2003.305.
Schultz M, Cisek J, Wabeke R: Simulated exposure of hospital emergency personnel to solvent vapors and respirable dust during decontamination of chemically exposed patients. Ann Emerg Med. 1995; 26(3): 324-329. doi:10.1016/S0196-0644(95)70081-1.
Cox RD: Decontamination and management of hazardous materials exposure victims in the emergency department. Ann Emerg Med. 1994; 23(4): 761-770. doi:10.1016/S0196-0644(94)70312-4.
Chilcott RP, Amlôt R: Primary Response Incident Scene Management (PRISM) Guidance for Chemical Incidents, Volume 1: Strategic Guidance for Mass Casualty Disrobe and Decontamination. Washington, DC: US Department of Health and Human Services, 2015. Available at https://www.hsdl.org/?view&did=792704. Accessed May 23, 2019.
Horton DK, Berkowitz Z, Kaye WE: Secondary contamination of ED personnel from hazardous materials events, 1995-2001. Am J
Emerg Med. 2003; 21(3): 199-204. doi:10.1016/S0735-6757(02)42245-0. 21. Wolbarst AB, Wiley AL, Nemhauser JB, et al.: Medical response to a major radiologic emergency: A primer for medical and public health practitioners. Radiology. 2010; 254(3): 660-677. doi:10.1148/radiol.09090330/-/DC1.
Hurst CG: Decontamination. In Sidell FR, Takafuji ET, Franz DR (eds.): Medical Aspects of Chemical and Biological Warfare. Washington, DC: Office of The Surgeon General at TMM Publications, 1997: 351-359. doi:10.1016/B978-0-08-044529-8.50018-5.
Matar H, Larner J, Kansagra S, et al.: Design and characterization of a novel in vitro skin diffusion cell system for assessing mass casualty decontamination systems. Toxicol In Vitro. 2014; 28(4): 492-501. doi:10.1016/j.tiv.2014.01.001.
Caneva DC, Kirk MA, Delaney JB: General approach to chemical attack. In Ciottone GR, Biddinger PD, Darling RG, et al. (eds.): Ciottone’s Disaster Medicine. 2nd ed. Philadelphia, PA: Elsevier, 2016: 471-479. doi:10.1016/B978-0-323-28665-7.00078-9.
Gaskin S, Pisaniello D, Edwards JW, et al.: Chlorine and hydrogen cyanide gas interactions with human skin: In vitro studies to inform skin permeation and decontamination in HAZMAT incidents. J Hazard Mater. 2013; 262: 759-765. doi:10.1016/j.jhazmat.2013.09.040.
Spiandore M, Piram A, Lacoste A, et al.: Efficacy of scalp hair decontamination following exposure to vapours of sulphur mustard simulants 2-chloroethyl ethyl sulphide and methyl salicylate. Chem Biol Interact. 2017; 267: 74-79. doi:10.1016/j.cbi.2016.07.018.
Okumura T, Seto Y, Fuse A: Countermeasures against chemical terrorism in Japan. Forensic Sci Int. 2013; 227(1-3): 2-6. doi:10.1016/j.forsciint.2012.11.008.
Chilcott RP: Managing mass casualties and decontamination. Environ Int. 2014; 72: 37-45. doi:10.1016/j.envint.2014.02.006.
Farra S, Smith S, French D, et al.: Development of an assessment instrument to evaluate performance of the skill of decontamination. Nurse Educ Today. 2015; 35: 1016-1022. doi:10.1016/j.nedt.2015.04.010.
Loke WK, U SH, Lau SK, et al.: Wet decontamination-induced stratum corneum hydration—Effects on the skin barrier function to diethylmalonate. J Appl Toxicol. 1999; 19(4): 285-290. doi:10.1002/(SICI)1099-1263(199907/08)19:4 < 285::AID-JAT580 > 3.0.CO;2-X.
Moody RP, Maibach HI: Skin decontamination: Importance of the wash-in effect. Food Chem Toxicol. 2006; 44: 1783-1788. doi:10.1016/j.fct.2006.05.020.
Vinson E: Managing bioterrorism mass casualties in an emergency department: Lessons learned from a rural community hospital disaster drill. Disaster Manag Response. 2007; 5(1): 18-21. doi:10.1016/j.dmr.2006.11.003.
Mikler J, Tenn C, Worek F, et al.: Immobilization of Russian VX skin depots by localized cooling: Implications for decontamination and medical countermeasures. Toxicol Lett. 2011; 206: 47-53. doi:10.1016/j.toxlet.2011.05.1047.
Braue EHJ, Smith KH, Doxzon BF, et al.: Efficacy studies of reactive skin decontamination lotion, M291 skin decontamination kit, 0.5% bleach, 1% soapy water, and skin exposure reduction paste against chemical warfare agents, Part 2: Guinea pigs challenged with soman. Cutan Ocul Toxicol. 2010; 30(1): 29-37. doi:10.3109/15569527.2010.515281.
National Research Council: Acute Exposure Guideline Levels for Selected Airborne Chemicals: Volume 3. Washington, DC: The National Academies Press, 2003. Available at https://doi.org/10.17226/10672. Accessed June 7, 2019.
Campbell LE, Lins RR, Pappas AG: Domestic Preparedness: Sarin Vapor Challenge and Corn Oil Protection Factor (PF) Testing of 3M BE10 Powered Air Purifying Respirator (PAPR) with AP3 Cartridge. Aberdeen Proving Groung, MD: Soldier and Biological Chemical Command, 2001.
Feldman RJ: Chemical agent simulant release from clothing following vapor exposure. Acad Emerg Med. 2010; 17(2): 221-224. doi:10.1111/j.1553-2712.2009.00650.x.
Bogan R, Maas HJ, Zimmermann T: Chemical stability of reactive skin decontamination lotion (RSDL®). Toxicol Lett. 2018; 293: 264-268. doi:10.1016/j.toxlet.2017.09.016.
Lydon HL, Hall CA, Dalton CH, et al.: Development of haemostatic decontaminants for treatment of wounds contaminated with chemical warfare agents. 3: Evaluation of in vitro topical decontamination efficacy using damaged skin. J Appl Toxicol. 2017; 37(8): 976-984. doi:10.1002/jat.3446.
Rolland P, Bolzinger M-A, Cruz C, et al.: Human scalp permeability to the chemical warfare agent VX. Toxicol In Vitro. 2011; 25: 1974-1980. doi:10.1016/j.tiv.2011.06.021.
Tokuda Y, Kikuchi M, Takahashi O, et al.: Prehospital management of sarin nerve gas terrorism in urban settings: 10 years of progress after the Tokyo subway sarin attack. Resuscitation. 2006; 68: 193-202. doi:10.1016/j.resuscitation.2005.05.023.
Morita H, Yanagisawa N, Nakajima T, et al.: Sarin poisoning in Matsumoto, Japan. Lancet. 1995; 346: 290-293. doi:10.1016/S0140-6736(95)92170-2.
Proctor SP, Heaton KJ, Heeren T, et al.: Effects of sarin and cyclosarin exposure during the 1991 Gulf War on neurobehavioral functioning in US army veterans. Neurotoxicology. 2006; 27(6): 931- 939. doi:10.1016/j.neuro.2006.08.001.
Schilling S, Follin P, Jarhall B, et al.: European concepts for the domestic transport of highly infectious patients. Clin Microbiol Infect. 2009; 15(8): 727-733. doi:10.1111/j.1469-0691.2009.02871.x.
Mason PE, Eadie JS, Holder AD: Prospective observational study of United States (US) Air Force Critical Care Air Transport Team Operations in Iraq. J Emerg Med. 2011; 41(1): 8-13. doi:10.1016/j.jemermed.2008.06.032.
US Department of Air Force: En Route Care and Aeromedical Evacuation Medical Operations. AFI 48-307. Vol. 1. Washington, DC: US Department of Air Force, 2017: 1-250. Available at https://static.e-publishing.af.mil/production/1/af_sg/publication/afi48-307v1/afi48-307v1.pdf. Accessed May 22, 2019.
Krieger K, Amlôt R, Rogers MB: Understanding public responses to chemical, biological, radiological and nuclear incidents—Driving factors, emerging themes and research gaps. Environ Int. 2014; 72: 66-74. doi:10.1016/j.envint.2014.04.017.
US Department of Defense: Detailed Specification: Joint Service Lightweight Integrated Suit Technology (JSLIST) Coat and Trouser, Chemical Protective. MILDTL-32102. Washington, DC: US Department of Defense, 2002: 1-61. Available at https://quicksearch.dla.mil/qsDocDetails.aspx?ident_number=211488. Accessed May 22, 2019.
US Army Medical Deparment Center and School: CBRN Decontamination: Multiservice Tactics, Techniques, and Procedures for Chemical, Biological, Radiological, and Nuclear Decontamination. Fort Sam Houston, TX: US Army Medical Deparment Center and School, 2006.
Timperley CM, Abdollahi M, Al-Amri AS, et al.: Advice on assistance and protection from the Scientific Advisory Board of the Organisation for the Prohibition of Chemical Weapons: Part 2. On preventing and treating health effects from acute, prolonged, and repeated nerve agent exposure, and the identif. Toxicology. 2019; 413: 13-23. doi:10.1016/j.tox.2018.11.009.
Masson P, Lushchekina SV: Emergence of catalytic bioscavengers against organophosphorus agents. Chem Biol Interact. 2016; 259: 319-326. doi:10.1016/j.cbi.2016.02.010.
Falach R, Sapoznikov A, Alcalay R, et al.: Generation of highly efficient equine-derived antibodies for post-exposure treatment of ricin intoxications by vaccination with monomerized ricin. Toxins. 2018; 10(11): 466. doi:10.3390/toxins10110466.
Gal Y, Mazor O, Alcalay R, et al.: Antibody/doxycycline combined therapy for pulmonary ricinosis: Attenuation of inflammation improves survival of ricin-intoxicated mice. Toxicol Rep. 2014; 1: 496-504. doi:10.1016/j.toxrep.2014.07.013.
Bailey MM, Heddleston JM, Davis J, et al.: Functionalized, carbon nanotube material for the catalytic degradation of organophosphate nerve agents. Nano Res. 2014; 7: 2-12. doi:10.1007/s12274.
Sharma N, Chaudhary M, Butola BS, et al.: Preparation, characterization and evaluation of the zinc titanate and silver nitrate incorporated wipes for topical chemical and biological decontamination. Mater Sci Eng C. 2019; 96: 183-196. doi:10.1016/j.msec.2018.10.056.
Ruxton K, Head CR, Clewes RJ, et al.: Detection and identification of chemical warfare agents using mid wave infrared active hyperspectral imaging. Proc SPIE. 2018; 10629: 1062904-1-18.doi:10.1117/12.2302519.
Published
How to Cite
Issue
Section
License
Copyright 2007-2023, Weston Medical Publishing, LLC
All Rights Reserved
